caprylates has been researched along with Colorectal Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, C; Boengler, K; Brunner, T; Christmann, M; Demuth, P; Fahrer, J; Huber, M; Linnebacher, M; Rasenberger, B; Seiwert, N; Wittmann, S | 1 |
Ducatman, AM; Frisbee, S; Innes, KE; Wimsatt, JH | 1 |
Amalaradjou, MA; Baskaran, SA; Narayanan, A; Venkitanarayanan, K | 1 |
Chu, Y; Kuai, R; Li, J; Ma, J; Miao, C; Peng, H; Wang, S; Zhang, Y | 1 |
4 other study(ies) available for caprylates and Colorectal Neoplasms
Article | Year |
---|---|
The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in Colorectal Cancer Therapy in a Bim-Dependent Manner.
Topics: Animals; Antineoplastic Agents; Caprylates; Cell Line, Tumor; Colorectal Neoplasms; Humans; Male; Mice; Sulfides; Survival Analysis | 2022 |
Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.
Topics: Adult; Aged; Aged, 80 and over; Alkanesulfonic Acids; Appalachian Region; Caprylates; Chi-Square Distribution; Colorectal Neoplasms; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Fluorocarbons; Health Care Surveys; Humans; Linear Models; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Time Factors; Water Pollutants, Chemical; Young Adult | 2014 |
Anticarcinogenic properties of medium chain fatty acids on human colorectal, skin and breast cancer cells in vitro.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Caproates; Caprylates; Caspase 8; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Decanoic Acids; Down-Regulation; Female; Goats; HCT116 Cells; Humans; Milk; Nuclear Receptor Subfamily 4, Group A, Member 1; Skin Neoplasms; Up-Regulation | 2015 |
Perfluorooctanoic acid enhances colorectal cancer DLD-1 cells invasiveness through activating NF-κB mediated matrix metalloproteinase-2/-9 expression.
Topics: Blotting, Western; Caprylates; Cell Line, Tumor; Colorectal Neoplasms; Environmental Pollutants; Fluorescent Antibody Technique; Fluorocarbons; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; Real-Time Polymerase Chain Reaction | 2015 |